首页 | 本学科首页   官方微博 | 高级检索  
     


Gadodiamide injection as a contrast medium for MRI of the central nervous system: a comparison with gadolinium-DOTA
Authors:D. Balériaux  C. Matos  D. De Greef
Affiliation:(1) Department of Neuroradiology, University Hospital Erasme, Route de Lennik, 808, B-1070 Brussels, Belgium;(2) Nycomed S.A., Brussels, Belgium
Abstract:The tolerance and diagnostic efficacy of a new nonionic, intravenous MRI contrast medium, gadodiamide injection (Omniscan®) are reported and compared with those of gadolinium-DOTA after completion of a double-blind, randomized, parallel study in 60 patients using a dose of 0.1 mmol/kg. Two patients were excluded from the statistical analysis after trial entrance since no contrast medium was injected. The indications for the MRI examination were known or suspected CNS lesions. Vital signs, chemical and haematological parameters were monitored. No significant abnormalities were observed, confirming the excellent tolerance of both contrast media. The usefulness of gadolinium-containing contrast media was again documented, since in 8.6% (5/58) of the patients the lesion(s) could be seen only after injection. Contrast enhancement was seen in 87.8% (43/49) of the patients with abnormal findings, and provided additional diagnostic information in 24.5% (12/49). Lack of contrast enhancement in 12.2% (6/49) of patients with abnormal findings was a significant negative finding.
Keywords:Magnetic resonance imaging  Brain  Spine  Contrast enhancement
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号